Anatomical and Perioperative Predisposing Factor for Limb Occlusion of Incraft Infrarenal Endograft (LIMIT Study)

IRCCS San Raffaele1 site in 1 country400 target enrollmentFebruary 15, 2022

ConditionsAneurysm Abdominal

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Aneurysm Abdominal
Sponsor: IRCCS San Raffaele
Enrollment: 400
Locations: 1
Primary Endpoint: limb occlusion
Status: Completed
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The aim was to determine, within the patient enrolled in three controlled prospective studies, INNOVATION, INSPIRATION and INSIGHT (Sponsor: Cordis, A Cardinal Health Company) studies which are preoperative and postoperative anatomical risk factors associated to limb occlusion. In the three studies the total number of enrolled patients was 400, of whom 134 enrolled in the US

Registry

clinicaltrials.gov

Start Date

February 15, 2022

End Date

October 31, 2022

Last Updated

3 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

IRCCS San Raffaele

Responsible Party

Principal Investigator

Bertoglio Luca

Principal Investigator

IRCCS San Raffaele

Eligibility Criteria

Inclusion Criteria

•Patients with abdominal aortic aneurysm, who have been treated with the INCRAFT® Grafting System (AAA Stent-Graft System).
•All cases treated with Incraft who were enrolled in three controlled prospective studies, INNOVATION, INSPIRATION and INSIGHT (Sponsor: Cordis, A Cardinal Health Company)